Original Article
Copyright
©2010 Baishideng Publishing Group Co. , Limited. All rights reserved.
World J Gastroenterol. Nov 28, 2010; 16(44): 5565-5581
Published online Nov 28, 2010. doi: 10.3748/wjg.v16.i44.5565
Table 1 Relevant parameters in serum (mean ± SE)
Group Amylase (IU/L) Lipase (IU/L) TNF-α (pg/mL) LDH (IU/L) Stress (-) Veh 402 ± 23 12 ± 2 BD 299 ± 21 Cer 569 ± 31 44 ± 3 BD 358 ± 23 Anti-TNF-α + Cer 572 ± 43 42 ± 5 BD 327 ± 27 Stress (+) Veh 475 ± 21 21 ± 3 12 ± 2a 612 ± 41 Cer 3997 ± 226a 1793 ± 118a 42 ± 4a 3410 ± 218a Anti-TNF-α + Cer 1895 ± 103c 714 ± 45c 16 ± 2c 1534 ± 121c
Table 2 Histopathological score in pancreatic tissue (mean ± SE)
Group Edema Hemorrhage Leukocyte infiltrate Necrosis Stress (-) Veh 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 Cer 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 Anti-TNF-α + Cer 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 Stress (+) Veh 0.49 ± 0.06 0.00 ± 0.00 0.39 ± 0.05 0.00 ± 0.00 Cer 1.28 ± 0.11a 3.11 ± 0.17a 2.19 ± 0.10a 3.12 ± 0.15a Anti-TNF-α + Cer 2.19 ± 0.17c 1.21 ± 0.17c 1.32 ± 0.10c 1.37 ± 0.19c
Table 3 Inflammatory parameters in pancreatic tissue (mean ± SE)
Group TNF-α (ng/mg DNA) HIF-1α (ng/mg DNA) Active trypsin (nmol/mg DNA) NF-κB (p65) (μg/mg DNA) NF-κB (p50) (μg/mg DNA) MPO (U/mg DNA) LPO (nmol/mg DNA) MDA (μmol/mg DNA) Stress (-) Veh BD BD 0.11 ± 0.02 43 ± 5 0.48 ± 0.04 0.00 ± 0.00 BD 0.71 ± 0.03 Cer BD BD 0.23 ± 0.04 46 ± 6 0.51 ± 0.05 0.00 ± 0.00 BD 0.89 ± 0.05 Anti-TNF-α + Cer BD BD 0.22 ± 0.05 44 ± 3 0.50 ± 0.03 0.00 ± 0.00 BD 0.84 ± 0.05 Stress (+) Veh 1.6 ± 0.2a 0.9 ± 0.1a 0.37 ± 0.06 72 ± 6 0.84 ± 0.07 1.41 ± 0.07 27 ± 2 2.05 ± 0.11 Cer 5.4 ± 0.3a 3.6 ± 0.3a 4.15 ± 0.32a 389 ± 25a 5.54 ± 0.35a 15.90 ± 0.66a 316 ± 20a 22.16 ± 0.69a Anti-TNF-α + Cer 2.0 ± 0.2c 1.5 ± 0.3c 1.79 ± 0.21c 221 ± 18c 2.65 ± 0.24c 7.14 ± 0.38c 171 ± 14c 12.38 ± 0.47c
Table 4 Inflammatory parameters in blood (mean ± SE)
Group Leukocytes (ng/mL) CRP (mg/dL) HSP-72 (pg/mL) IL-6 (pg/mL) IL-10 (pg/mL) MIP-1α (pg/mL) Stress (-) Veh 5900 ± 240 0.0 ± 0.0 558 ± 27 BD BD 7 ± 1 Cer 6111 ± 248 0.0 ± 0.0 866 ± 32 BD BD 9 ± 1 Anti-TNF-α + Cer 6005 ± 244 0.0 ± 0.0 817 ± 49 BD BD 8 ± 1 Stress (+) Veh 7139 ± 250 1.5 ± 0.2a 899 ± 63 66 ± 6a 75 ± 5a 54 ± 4a Cer 21 222 ± 976a 24.9 ± 1.3a 2648 ± 159a 1115 ± 54a 1404 ± 148a 318 ± 23a Anti-TNF-α + Cer 12 733 ± 586c 12.4 ± 0.8c 1805 ± 112c 417 ± 38c 596 ± 68c 127 ± 11b
Table 5 General biochemical assays in blood (mean ± SE)
Group Glucose (mg/dL) Urea (mg/dL) Creatinine (mg/dL) Calcium (mg/dL) Proteins (g/dL) AST (IU/L) ALT (IU/L) Hematocrit (%) Stress (-) Veh 139 ± 13 39 ± 4 0.48 ± 0.03 13.02 ± 0.57 8.51 ± 0.39 192 ± 21 88 ± 7 40 ± 5 Cer 153 ± 14 55 ± 4 0.65 ± 0.09 11.08 ± 0.48 7.46 ± 0.28 298 ± 32 155 ± 14 42 ± 4 Anti-TNF-α + Cer 148 ± 12 52 ± 5 0.67 ± 0.08 10.91 ± 0.70 7.51 ± 0.43 293 ± 20 149 ± 9 41 ± 5 Stress (+) Veh 118 ± 11a 38 ± 5 0.50 ± 0.05 11.72 ± 0.61 8.48 ± 0.22 201 ± 26 95 ± 9 36 ± 5a Cer 294 ± 26a 105 ± 9a 1.94 ± 0.50a 9.03 ± 0.33a 6.02 ± 0.19a 432 ± 35a 219 ± 19a 41 ± 3 Anti-TNF-α + Cer 189 ± 16c 73 ± 8c 1.14 ± 0.24c 9.63 ± 0.58 6.76 ± 0.35c 356 ± 29c 187 ± 19c 39 ± 4
Table 6 Pancreatic caspases (mean ± SE)
Group CASP-2 CASP-3 CASP-8 CASP-9 Stress (-) Veh 34 ± 6 25 ± 2 45 ± 5 40 ± 7 Cer 56 ± 12 63 ± 9 87 ± 11 82 ± 8 Anti-TNF-α + Cer 50 ± 7 39 ± 5 72 ± 7 68 ± 9 Stress (+) Veh 124 ± 15 118 ± 10 189 ± 11 158 ± 16 Cer 995 ± 88a 838 ± 74a 1123 ± 103a 1079 ± 70a Anti-TNF-α + Cer 696 ± 47c 544 ± 58c 887 ± 65c 679 ± 48c
Table 7 Energy metabolism in pancreatic tissue (mean ± SE)
Group ATP (μmol/mg protein) ATP loss (%) ADP/ATP ratio Stress (-) Veh 9.1 ± 0.4 0.0 ± 4.4 0.32 ± 0.04 Cer 6.8 ± 0.5 25.3 ± 5.5 0.38 ± 0.05 Anti-TNF-α + Cer 6.9 ± 0.6 24.2 ± 6.6 0.36 ± 0.04 Stress (+) Veh 7.3 ± 0.5 19.8 ± 5.5 0.40 ± 0.06 Cer 2.6 ± 0.4a 71.4 ± 4.4a 0.94 ± 0.11a Anti-TNF-α + Cer 5.3 ± 0.3c 41.8 ± 3.3c 0.63 ± 0.07c
Table 8 Histopathological score in lung tissue (mean ± SE)
Group Edema Hemorrhage Leukocyte infiltrate Stress (-) Veh 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 Cer 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 Anti-TNF-α + Cer 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 Stress (+) Veh 0.36 ± 0.04 0.00 ± 0.00 0.30 ± 0.03 Cer 1.51 ± 0.11a 2.73 ± 0.58a 1.63 ± 0.54a Anti-TNF-α + Cer 1.80 ± 0.21c 1.21 ± 0.08c 0.73 ± 0.05c
Table 9 Inflammatory parameters in lung tissue (mean ± SE)
Group TNF-α (ng/mg DNA) MPO (U/mg DNA) NF-κB (p65) (μg/mg DNA) NF-κB (p50) (μg/mg DNA) Stress (-) Veh BD 0.00 ± 0.00 23 ± 2 0.27 ± 0.02 Cer BD 0.00 ± 0.00 24 ± 2 0.30 ± 0.02 Anti-TNF-α + Cer BD 0.00 ± 0.00 24 ± 3 0.29 ± 0.03 Stress (+) Veh 1.3 ± 0.1a 0.89 ± 0.12 43 ± 5 0.51 ± 0.03 Cer 4.2 ± 0.3a 12.10 ± 0.56a 251 ± 19a 2.92 ± 0.28a Anti-TNF-α + Cer 1.8 ± 0.2c 5.04 ± 0.29c 107 ± 9c 1.13 ± 0.11c
Table 10 Lung caspases (mean ± SE)
Group CASP-2 CASP-3 CASP-8 CASP-9 Stress (-) Veh 18 ± 3 20 ± 2 21 ± 5 22 ± 4 Cer 27 ± 3 29 ± 4 32 ± 5 29 ± 3 Anti-TNF-α + Cer 26 ± 2 24 ± 3 24 ± 4 22 ± 3 Stress (+) Veh 97 ± 11 103 ± 9 99 ± 8 104 ± 12 Cer 853 ± 81a 912 ± 101a 824 ± 77a 917 ± 85a Anti-TNF-α + Cer 597 ± 48c 592 ± 55c 560 ± 45c 568 ± 47c
Table 11 Energy metabolism in lung tissue (mean ± SE)
Group ATP (μmol/mg protein) ATP loss (%) ADP/ATP ratio Stress (-) Veh 10.3 ± 0.5 0.0 ± 4.9 0.20 ± 0.03 Cer 10.0 ± 0.3 2.9 ± 2.9 0.22 ± 0.02 Anti-TNF-α + Cer 10.1 ± 0.4 1.9 ± 3.8 0.21 ± 0.03 Stress (+) Veh 7.9 ± 0.7 25.5 ± 6.8 0.32 ± 0.05 Cer 3.6 ± 0.4a 66.0 ± 3.8a 0.72 ± 0.10a Anti-TNF-α + Cer 6.7 ± 0.6c 36.8 ± 5.7c 0.49 ± 0.06c
Table 12 Histopathological score in stomach tissue (mean ± SE)
Group Edema Hemorrhage Leukocyte infiltrate Necrosis Stress (-) Veh 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 Cer 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 Anti-TNF-α + Cer 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 Stress (+) Veh 3.25 ± 0.14b 1.55 ± 0.08a 1.26 ± 0.19a 0.95 ± 0.06a Cer 1.17 ± 0.08a 3.23 ± 0.29a 2.77 ± 0.16a 3.48 ± 0.32a Anti-TNF-α + Cer 1.96 ± 0.17c 2.23 ± 0.15c 1.63 ± 0.05c 1.57 ± 0.12c
Table 13 Stomach caspases (mean ± SE)
Group CASP-2 CASP-3 CASP-8 CASP-9 Stress (-) Veh 37 ± 4 32 ± 3 48 ± 5 39 ± 5 Cer 40 ± 5 32 ± 5 51 ± 4 40 ± 3 Anti-TNF-α + Cer 33 ± 4 30 ± 3 47 ± 4 39 ± 4 Stress (+) Veh 1358 ± 132a 1515 ± 154a 1479 ± 136a 1425 ± 126a Cer 798 ± 87a 824 ± 95a 868 ± 70a 832 ± 87a Anti-TNF-α + Cer 1089 ± 98c 1203 ± 107c 1108 ± 89c 1144 ± 102c
Table 14 Energy metabolism in stomach tissue (mean ± SE)
Group ATP (μmol/mg protein) ATP loss (%) ADP/ATP ratio Stress (-) Veh 13.4 ± 0.9 0.0 ± 6.7 0.16 ± 0.02 Cer 12.9 ± 0.7 3.7 ± 5.2 0.18 ± 0.03 Anti-TNF-α + Cer 13.0 ± 0.8 3.0 ± 6.0 0.17 ± 0.02 Stress (+) Veh 5.5 ± 0.4a 58.9 ± 3.0a 0.67 ± 0.07a Cer 2.3 ± 0.4a 82.8 ± 3.0a 1.14 ± 0.16a Anti-TNF-α + Cer 6.2 ± 0.6c 53.7 ± 4.5c 0.58 ± 0.06c